Celine Lam2026-08-04T21:11:34+00:00Interim Leadership in FDA-Regulated Operations: What to Do When a Seat Sits EmptyCeline Lam2026-08-04T21:11:34+00:00August 4th, 2026|
Celine Lam2026-07-09T12:55:47+00:00Computer System Validation (CSV): A Practical, Risk-Based OverviewCeline Lam2026-07-09T12:55:47+00:00July 6th, 2026|
Celine Lam2026-07-06T21:30:20+00:00Non-Conformances, CAPA, and Change Control: Three Tools Every Quality Team Needs to UnderstandCeline Lam2026-07-06T21:30:20+00:00May 29th, 2026|
Celine Lam2026-05-05T14:45:47+00:00What to Look for in a GMP Facility Design ReviewCeline Lam2026-05-05T14:45:47+00:00May 5th, 2026|
Celine Lam2026-03-12T18:59:13+00:00Dietary Supplement Manufacturing Compliance Case Studies: 21 CFR Part 111 & cGMP ExpertiseCeline Lam2026-03-12T18:59:13+00:00March 12th, 2026|
Celine Lam2026-02-27T17:10:04+00:00FDA Observations in Dietary Supplements: Trends and Part 111 Compliance RisksCeline Lam2026-02-27T17:10:04+00:00March 2nd, 2026|